GPD1 anticorps (N-Term)

N° du produit ABIN7879605

L’anticorps anti-GPD1 Polyclonal Lapin est utilisé pour la détection de GPD1 dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB, IHC et FACS.

Aperçu rapide pour GPD1 anticorps (N-Term) (ABIN7879605)

Antigène: GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GPD1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Détail du produit anti-GPD1 anticorps

Épitope: N-Term

Fonction: GPD1 Antibody / Glycerol-3-phosphate dehydrogenase 1

Purification: Immunogen affinity purified

Immunogène: A synthetic peptide corresponding to a sequence at the N-terminus of human GPD1 was used as the immunogen for the GPD1 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the GPD1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the GPD1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur GPD1

Antigène: GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))

Autre désignation: GPD1

Sujet: GPD1 antibody detects Glycerol-3-phosphate dehydrogenase 1, a cytosolic enzyme that catalyzes the reversible conversion of dihydroxyacetone phosphate to glycerol-3-phosphate, linking carbohydrate metabolism with lipid biosynthesis and energy regulation. GPD1 plays a crucial role in maintaining redox balance and metabolic flexibility. The GPD1 antibody is widely used in metabolic, biochemical, and endocrinological research to study lipid metabolism, redox cycling, and adipocyte differentiation.

GPD1 is encoded by the GPD1 gene located on human chromosome 12q13.12. The protein is approximately 349 amino acids long and localizes primarily in the cytoplasm. GPD1 functions in concert with its mitochondrial counterpart, GPD2, as part of the glycerophosphate shuttle that transfers reducing equivalents from NADH in the cytosol to the mitochondria for oxidative phosphorylation.

The GPD1 antibody detects a 37 kilodalton protein by western blot and shows cytosolic localization under immunofluorescence microscopy. GPD1 activity supports triglyceride synthesis in adipocytes and provides glycerol-3-phosphate as a substrate for lipid esterification. In muscle and liver, GPD1 contributes to energy metabolism by linking glycolysis to oxidative phosphorylation. Its regulation is sensitive to hormonal cues, including insulin and glucagon, and is modulated by redox state and nutrient availability.

Deficiency of GPD1 results in transient hypertriglyceridemia and hepatic steatosis due to impaired lipid processing. Genetic mutations have been associated with congenital lipodystrophy and metabolic syndrome. Increased GPD1 expression in adipose tissue correlates with obesity and insulin resistance, highlighting its importance in metabolic homeostasis.

Beyond energy metabolism, GPD1 influences cell signaling through regulation of NAD+/NADH balance and oxidative stress. It plays roles in thermogenesis, adipocyte differentiation, and lipid droplet biogenesis. NSJ Bioreagents provides a validated GPD1 antibody optimized for its applications, supporting studies into redox regulation, lipid metabolism, and energy homeostasis.

UniProt: P21695